Treatment and Disease Burden in a Cohort of People With Haemophilia Without Inhibitors in the United States
This underscores how the perspectives of people with haemophilia in real-world settings represent a valuable adjunct to clinical trial data. Such insights can potentially contribute to guide individualised treatment options and help address current unmet needs.
Authors
- Naveen Shridhar
- Amy D. Shapiro (ORCID: https://orcid.org/0000-0003-2821-7159)
- Emily Cibelli (ORCID: https://orcid.org/0000-0003-3137-4817)
- Allison P. Wheeler (ORCID: https://orcid.org/0000-0003-3967-4873)
- Cléa Percier
- Gillian Hanson
- Thomas Porstmann
Institutions
- University of Washington (US)
- Novo Nordisk (Switzerland) (CH)
- Washington Center (US)
- Novo Nordisk (India) (IN)
- Indiana Hemophilia and Thrombosis Center (US)
Publication Details
- Journal
- Haemophilia
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1111/hae.70078
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk